dc.creatorValenzuela Bonomo, Carlos
dc.creatorBarría, Teresa
dc.creatorGuerra, Ricardo
dc.creatorGarrido, Argelia
dc.date.accessioned2019-01-29T14:47:10Z
dc.date.available2019-01-29T14:47:10Z
dc.date.created2019-01-29T14:47:10Z
dc.date.issued1985
dc.identifierBiochemical and Biophysical Research Communications, Volumen 126, Issue 2, 2018, Pages 712-718
dc.identifier10902104
dc.identifier0006291X
dc.identifier10.1016/0006-291X(85)90243-8
dc.identifierhttp://repositorio.uchile.cl/handle/2250/160566
dc.description.abstractThe flavonoid silymarin, which is used as a therapeutical agent in the treatment of liver diseases, can inhibit the hemolysis and lipid peroxidation induced by phenylhydrazine on erythrocytes obtained from rats treated with the flavonoid. This effect is ascribed to the antioxidant properties as a free radical scavenger exhibited by the flavonoid. Silymarin failed to inhibit the glutathione depletion induced by phenylhydrazine on erythrocytes. It is proposed that the flavonoid acts at the membrane level of the cell avoiding the lipid peroxidative and fluidizing effect of phenylhydrazine. © 1985.
dc.languageen
dc.rightshttp://creativecommons.org/licenses/by-nc-nd/3.0/cl/
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 Chile
dc.sourceBiochemical and Biophysical Research Communications
dc.subjectBiochemistry
dc.subjectBiophysics
dc.subjectMolecular Biology
dc.titleInhibitory effect of the flavonoid silymarin on the erythrocyte hemolysis induced by phenylhydrazine
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución